This can create a serious challenge for employers considering funding them for weight loss, depending on the number of users within a covered population
Vineetha KK, Rao GM, Prabhu KA, Vinodchandran, Kavyashree, Marathe A, et al
Food & Drug Administration, FDA approves first oral GLP-1 treatment for type 2 diabetes (2019)
They describe reta as a "next-gen" GLP-1 drug, saying the injectable they are taking helped them cut fat and get lean without the muscle wasting that many people experience on Ozempic, Wegovy, Mounjaro, or Zepbound
Quick Answer: GLP-1 liquid refers to injectable solutions in pre-filled pens, administered subcutaneously into the abdomen, thigh, or upper arm, typically once daily or once weekly depending on the specific medication
Many people tolerate tirzepatide just fine with manageable side effects